Skip to content
Screener

Boston Scientific BSX Amortization of capitalized software and acquired intangible assets

Amortization of capitalized software and acquired intangible assets at other companies

TFX
TeleflexTFX
$34.05M+35.8%
Abbott logo
AbbottABT
Stryker logo
StrykerSYK
CONMED logo
CONMEDCNMD
AngioDynamics logo
AngioDynamicsANGO
AtriCure logo
AtriCureATRC

Other financials

Income statement

See full
Revenue$5.4B+7.5%
Gross profit$3.8B+12.4%
Operating income$1.2B+43.8%
Net income$907.0M+14.1%
EPS (diluted)$0.61+15.1%

Balance sheet

See full
Cash & equivalents$850.0M+146%
Total debt$659.0M-94.1%
Total equity$25.9B+16.4%
Total assets$44.4B+10.5%

Cash flow

See full
Operating cash flow$348.0M-35.7%
CapEx$177.0M-5.3%
Free cash flow$171.0M-51.7%

Valuation

See full
Market cap$73.13B-52.2%
P/E19.9×-41.3×
P/S3.5×-4.8×

Profitability

See full
Gross margin69.9%+1.7pp
Operating margin19.8%+2.8pp
Net margin17.5%+4.0pp
FCF margin16.9%-0.3pp

Returns & leverage

See full
Return on equity14.8%+5.2pp
Debt / equity-0.5×
Current ratio1.9×+0.4×

Where this comes from

Reported directly by Boston Scientific in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.

The source filing: Boston Scientific’s 8-K, filed July 29, 2026. Open the filing →

Filed
Jul 29, 2026, 6:33 AM EDT
Accession
0000885725-26-000051

FAQ

What is Boston Scientific's amortization of capitalized software and acquired intangible assets?
Boston Scientific (BSX) reported amortization of capitalized software and acquired intangible assets of $233M in Q2 2026.
How has Boston Scientific's amortization of capitalized software and acquired intangible assets changed year-over-year?
Boston Scientific's amortization of capitalized software and acquired intangible assets increased by 3.6% year-over-year, from $225M to $233M.
What is the long-term trend for Boston Scientific's amortization of capitalized software and acquired intangible assets?
Over 4 years (2021 to 2025), Boston Scientific's amortization of capitalized software and acquired intangible assets has grown at a 4.9% compound annual growth rate (CAGR), from $741M to $897M.

Ask your AI about Boston Scientific's amortization of capitalized software and acquired intangible assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude